Neurological Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neurological Disorders stocks.

Neurological Disorders Stocks Recent News

Date Stock Title
May 1 MYO Myomo to Report First Quarter Financial Results on May 8, 2024
May 1 PTCT PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
May 1 HRMY Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice
May 1 HRMY HRMY or TECH: Which Is the Better Value Stock Right Now?
May 1 HRMY Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript
May 1 OVID Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
May 1 IONS 4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
May 1 DNLI Denali Therapeutics Announces Completion of Enrollment for Regimen G Evaluating eIF2B Agonist DNL343 in the Phase 2/3 HEALEY ALS Platform Trial
Apr 30 HRMY Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
Apr 30 HRMY Harmony Biosciences: Company's Q1 Update Music To Investor Ears (Upgrade)
Apr 30 HRMY Harmony Biosciences Holdings, Inc (HRMY) Q1 2024 Earnings Call Transcript
Apr 30 PTCT PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
Apr 30 HRMY Harmony Biosciences Holdings, Inc. 2024 Q1 - Results - Earnings Call Presentation
Apr 30 HRMY Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View
Apr 30 IONS Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Apr 30 HRMY Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024
Apr 30 HRMY Harmony Biosciences acquires Epygenix gaining rare epilepsy pipeline
Apr 30 HRMY Harmony Biosciences Non-GAAP EPS of $0.88 beats by $0.10, revenue of $154.6M misses by $0.19M
Apr 30 HRMY Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
Apr 30 HRMY Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
Neurological Disorders

Neurological disorders are conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. These disorders can affect how the body functions, including movement, speech, and memory. Examples of neurological disorders include Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, epilepsy, and migraine.

Browse All Tags